The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs—disulfiram and ritonavir
Crossref DOI link: https://doi.org/10.1186/s40880-015-0010-1
Published Online: 2015-04-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kast, Richard E
License valid from 2015-04-09
Article History
Received: 14 October 2014
Accepted: 12 January 2015
First Online: 9 April 2015